You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

daclatasvir

Showing 1 - 25 of 200
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HCV Trial in Cairo (Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets)

Recruiting
  • HCV
  • Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets
  • Cairo, Egypt
    Faculty of Medicine, Ain-Shams University Research Institute-Cli
May 2, 2023

Sofosbuvir/Daclatasvir in HCV-infected Lactating Women

Recruiting
  • Hepatitis C Virus Infection
  • Pharmacokinetic test
  • Cairo, Non-US, Egypt
    Faculty of Medicine Ain Shams University Research Institute- Cli
Aug 21, 2022

HCV Infection Trial in Phnom Penh (Sofosbuvir/Daclatasvir)

Not yet recruiting
  • HCV Infection
  • Phnom Penh, Cambodia
    Clinical Trial Unit (Ctu)
Aug 7, 2023

COVID-19 Trial in Sao Paulo (Atazanavir, Daclatasvir 60 mg, Sofusbuvir + Daclastavir 60 mg)

Active, not recruiting
  • COVID-19
  • Sao Paulo, SP, Brazil
    Hospital do Coracao
Feb 25, 2022

Proportion of Hepatic Toxicity and All Adverse Drug Reactions in

Completed
  • Hepatitis C
    • Tokyo, Japan
      Local Institution
    Feb 7, 2022

    Hepatitis C Trial in Seoul

    Completed
    • Hepatitis C
      • Seoul, Korea, Republic of
        Local Institution
      Jan 6, 2022

      Covid19, SARS-CoV Infection Trial in Johannesburg (Nitazoxanide, Sofosbuvir/Daclatasvir)

      Completed
      • Covid19
      • SARS-CoV Infection
      • Johannesburg, Gauteng, South Africa
      • +1 more
      Jun 6, 2022

      Chinese Participants With Chronic Hepatitis C (CHC)

      Terminated
      • Chronic Hepatitis C
        • Beijing, Beijing, China
        • +1 more
        Aug 27, 2021

        Male Infertility, HCV Trial in Al Qalyubiyah, Banha (Sofosbuvir +daclatasvir+ simeprevir+Ribavirin)

        Recruiting
        • Male Infertility
        • HCV
        • Sofosbuvir +daclatasvir+ simeprevir+Ribavirin
        • Al Qalyūbīyah, Benha, Egypt
        • +1 more
        Nov 7, 2022

        Hepatitis C Treatment Study in Myanmar

        Withdrawn
        • Hepatitis C
        • Sofosbuvir 400 mg
        • Yangon, Myanmar
          Medical Action Myanmar
        Dec 3, 2021

        Chronic Hepatitis C, Hepatitis C Virus, Genotype 3 Hepatitis C Virus Trial (ABT-493/ABT-530, Sofosbuvir, Daclatasvir)

        Completed
        Has Results
        • Chronic Hepatitis C
        • +2 more
        • (no location specified)
        Jul 9, 2021

        Hepatitis C, Chronic Hepatitis Trial in Melbourne, Barcelona (Daclatasvir, Sofosbuvir)

        Terminated
        Has Results
        • Hepatitis C
        • Chronic Hepatitis
        • Melbourne, Victoria, Australia
        • +1 more
        Apr 16, 2021

        Covid19 Trial in Alexandria (Sofosbuvir 400 MG/ Daclatasvir 60mg)

        Completed
        • Covid19
        • Sofosbuvir 400 MG/ Daclatasvir 60mg
        • Alexandria, Egypt
          Amr Aly Abd elmoety
        Feb 25, 2021

        Hepatitis C, Diabetes, Insulin Resistance Trial in Nijmegen (Daclatasvir, Metformin)

        Completed
        • Hepatitis C
        • +2 more
        • Nijmegen, Netherlands
          CRCN, Radboud University Medical Center
        Dec 4, 2020

        Hepatitis C, HIV Trial in Nijmegen (Daclatasvir, Atazanavir, Ritonavir)

        Completed
        • Hepatitis C
        • HIV
        • Daclatasvir
        • +3 more
        • Nijmegen, Netherlands
          CRCN, Radboud University Medical Center
        Dec 4, 2020

        Hepatitis C, Drug Use, Viral Hepatitis C Trial in Hai Phong, H?i Phòng (Sofosbuvir 400 mg and Daclatasvir 60 mg, Sofosbuvir 400

        Completed
        • Hepatitis C
        • +2 more
        • Sofosbuvir 400 mg and Daclatasvir 60 mg
        • +3 more
        • Hai Phong, Vietnam
        • +1 more
        Jan 28, 2021

        COVID-19 Trial in Johannesburg (Standard of care (Paracetamol), Artesunate-amodiaquine, Pyronaridine-artesunate)

        Completed
        • COVID-19
        • Standard of care (Paracetamol)
        • +4 more
        • Johannesburg, South Africa
          Ezintsha, Wits Reproductive Health & HIV Institute University of
        Sep 16, 2021

        HIV-1-infection, Hepatic Impairment Trial in Smolensk (Elpida®, Dolutegravir, Sofosbuvir)

        Completed
        • HIV-1-infection
        • Hepatic Impairment
        • Smolensk, Russian Federation
          Regional State Budgetary Healthcare Institution "Smolensk Region
        Jan 10, 2022

        Kidney Failure, Chronic, Hepatitis C Trial in Lucknow (Sofosbuvir, Daclatasvir 60 mg)

        Completed
        • Kidney Failure, Chronic
        • Hepatitis C
        • Lucknow, Uttar Pradesh, India
          Sanjay Gandhi Postgraduate Institute of Medical Sciences
        Apr 4, 2021

        Fixed-dose Combination Sofosdac® 400mg/60mg in Chronic Hepatitis

        Completed
        • Chronic Hepatitis c
        • Sofosdac®
        • Boufarik, Blida, Algeria
        • +3 more
        Nov 16, 2021

        Vit. B12 and Folic Acid in Cirrhotics Received Sofosbuvir and

        Completed
        • Liver Cirrhoses
        • +2 more
        • Vitamin B12 and Folic Acid
        • Assiut, Egypt
          Mohamed Shaban Redwan Helal
        Oct 14, 2020

        Chronic Hepatitis C Infection, HBV Coinfection, Hepatitis B Reactivation Trial in Hong Kong (Ledipasvir/Sofosbuvir, Sofosbuvir

        Completed
        • Chronic Hepatitis C Infection
        • +2 more
        • Hong Kong, Hong Kong, China
          Humanity and Health GI and Liver Centre
        Aug 27, 2021

        COVID Trial in Tanta (sofosbuvir, Sofosbuvir ledipsavir, Daclatasvir)

        Recruiting
        • COVID
        • Tanta, Egypt
          Sherief Abd-Elsalam
        Dec 3, 2020

        Chronic Hepatitis C Virus Infection Trial ((SOF and DCV), (SOF, DCV, and RBV))

        Completed
        • Chronic Hepatitis C Virus Infection
        • (SOF and DCV)
        • (SOF, DCV, and RBV)
        • (no location specified)
        May 13, 2020

        Chronic Hepatitis C Patients Previously Treated With

        Completed
        • Hepatitis C
        • Non-interventional
        • Beijing, Beijing, China
          Local Institution
        Jun 16, 2020